| Literature DB >> 33806967 |
José Manuel Pérez de la Lastra1, Patricia Asensio-Calavia2, Sergio González-Acosta1, Victoria Baca-González1, Antonio Morales-delaNuez1.
Abstract
Bats are unique in their potential to serve as reservoir hosts for intracellular pathogens. Recently, the impact of COVID-19 has relegated bats from biomedical darkness to the frontline of public health as bats are the natural reservoir of many viruses, including SARS-Cov-2. Many bat genomes have been sequenced recently, and sequences coding for antimicrobial peptides are available in the public databases. Here we provide a structural analysis of genome-predicted bat cathelicidins as components of their innate immunity. A total of 32 unique protein sequences were retrieved from the NCBI database. Interestingly, some bat species contained more than one cathelicidin. We examined the conserved cysteines within the cathelin-like domain and the peptide portion of each sequence and revealed phylogenetic relationships and structural dissimilarities. The antibacterial, antifungal, and antiviral activity of peptides was examined using bioinformatic tools. The peptides were modeled and subjected to docking analysis with the region binding domain (RBD) region of the SARS-CoV-2 Spike protein. The appearance of multiple forms of cathelicidins verifies the complex microbial challenges encountered by these species. Learning more about antiviral defenses of bats and how they drive virus evolution will help scientists to investigate the function of antimicrobial peptides in these species.Entities:
Keywords: SARS-COV-2; bat; bioinformatics; cathelicidin; genome; in silico
Mesh:
Substances:
Year: 2021 PMID: 33806967 PMCID: PMC8004601 DOI: 10.3390/molecules26061811
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Number of predicted unique cathelicidin proteins found for each bat species that have on-going sequencing projects by February 2021, in comparison with the median genome length and protein counts. Source: NCBI database (genome).
| Bat Species | Genome ID | Length (Mb) | Proteins | Cathelicidins |
|---|---|---|---|---|
|
| 12026 | 2316.20 | 42,600 | 1 |
|
| 15041 | 2063.80 | 29,845 | 2 |
|
| 11703 | 2026.63 | 49,822 | 1 |
|
| 15002 | 2236.58 | 45,831 | 1 |
|
| 44094 | 1803.10 | 29,787 | 1 |
|
| 93829 | 2315.57 | 53,797 | 1 |
|
| 18281 | 2107.24 | 40,808 | 2 |
|
| 14635 | 2059.80 | 33,106 | 2 |
|
| 614 | 2034.58 | 43,106 | 4 |
|
| 43810 | 2148.60 | 61,156 | 3 |
|
| 75334 | 2080.20 | 46,999 | 4 |
|
| 93828 | 1775.69 | 39,923 | 1 |
|
| 12056 | 1985.96 | 39,693 | 1 |
|
| 757 | 2198.28 | 43,630 | 1 |
|
| 10960 | 2072.56 | 45,117 | 3 |
|
| 7672 | 1904.62 | 61,105 | 2 |
|
| 95481 | 2098.36 | 43,530 | 2 |
Bat cathelicidin sequences rejected from further structural analysis, due to lack of conserved cysteines within the cathelin-like region or to the missing of the portion of the cathelicidin active peptide. The interval shows the region of homology with the superfamily member pfam00666.
| Bat Species | Accession No. | Interval | Cysteines | Peptide Length |
|---|---|---|---|---|
|
| XP_036984419 | 30–104 | 2 | 14 |
|
| XP_036905728 | 30–127 | 4 | 10 |
|
| XP_005867268 | 33–131 | 4 | 3 |
|
| ELK24988 | 39–82 | 3 | 43 |
|
| ELK24989 | 32–126 | 4 | 7 |
|
| XP_006914980 | 23–102 | 3 | 67 |
|
| XP_011373748 | 23–94 | 2 | 64 |
Figure 1Multi-sequence alignments of the conserved cathelin region of bat cathelicidins using the default parameters of CLUSTALW (https://www.genome.jp/tools-bin/clustalw, accessed on: 10 January 2021). Gaps are inserted to optimize the alignment. Conserved cysteines are shaded and identical amino acids are indicated by asterisks, whereas those with high or low similarities are indicated by colons and dots, respectively.
Figure 2Phylogenetic tree constructed from the multi-sequence alignments of the conserved cathelin region of bat cathelicidins. The tree was constructed using FastTree with default parameters. FastTree infers maximum-likelihood phylogenetic trees using the Neighbor Joining method and computes local support values with the Shimodaira-Hasegawa test.
Predicted cathelicidin active peptides of the bat sequences corresponding to the C-terminal portion of the protein after removal of the cathelin-like region.
| Bat Species | Accession | Sequence of Active Peptide |
|---|---|---|
|
| XP_024421798 | RVPGWLRKTGRAIGNAIRIVGPILPIFFPRG |
|
| XP_024421797 | G |
|
| XP_008154130 | KFNARKLG |
|
| XP_019486615 | ILGRLRDLLRRGGR |
|
| XP_014395994 | ELNIENLG |
|
| XP_006108362 | RFNYDRLSNIIKRGGYKLGEGLEIVGGILRRS |
|
| XP_006108800 | GLILWGWRPPGALGRLWDRIRYRVRRPRDVSENLSP |
|
| XP_006108360 | LNPLIKAGIFILKHRRPIGRGIEITGRGIKKFFSK |
|
| XP_006108361 | LNPWIIGGALAWKHRRPIGRGLEKAGSGIKRFFSKRSPEQEP |
|
| XP_036123304 | SLG |
|
| XP_036189569 | LNPDTPKPVSFTLKETVCPRTTRQPPEECDFKENGLVKVCGGTVTLDQDTDYYDVHCEEIKDVAIRPLVSGALFLWKNRRPIGWGIEKTGRGIKRIFSKRSPEQEP |
|
| KAF6310192 | AIRPLVSGALFLWKNRRPIGWGIEKTGRGIKRIFSKRSPEQEP |
|
|
|
|
|
| XP_016058295 | KLRGLLGGLLRKGGRKIGEGIEGFGRRIKNFFSNLSPREES |
|
| KAF6098810 | QLGDTEQTAFRGGSTNGEFDRFRRFPPFPRIPRFPRFPRFP |
|
|
|
|
|
| XP_035886276 | ILGPALRIGGRIAGRIAGKLIGDAINRHRERNRQRRG |
|
|
|
|
|
| XP_036288304 | NLDNLIQKGREKLGRLRELFRKGGQKVG |
|
| XP_036075573 | RGLG |
|
|
|
|
|
| KAF6312594 | KLGGRLR |
|
|
|
|
|
| KAF6312595 | SGPFWVAGSDGTWRMELPMEQLTTAPSRAEKAPSTLSSSLNLRPTGTGSAIP |
|
| XP_036905727 | GQISKFRRFRNPFRRFRIHGKITVTFR |
| * | NP_004336 | LLG |
LPS binding domain of CAP18 is highlighted in red. Duplicate peptides are shadowed in gray. * The human cathelicidin peptide LL-37 was included as an internal control of the bioinfomatic analysis.
Figure 3Structure of an amphipathic helix. Yellow/green residues of the upper helical view are hydrophobic and form the hydrophobic face, whereas purple residues of the helix are polar residues and are located at the opposite face. This feature is typical of most antimicrobial peptides and allow them to interact with membranes (down).
Figure 4Bioinformatic analysis of bat cathelicidins (part 1). Net charge, secondary structure, hydrophobicity of helixes, and interaction with membranes and SARS-CoV-2 region binding domain (RBD) of the Spike protein were computed. The analysis includes predictions of biological properties of the peptides, such as antibacterial, antifungal, antiviral, and hemolytic activities.
Figure 5Bioinformatic analysis of bat cathelicidins (part 2). Net charge, secondary structure, hydrophobicity of helixes, interaction with membranes and with the SARS-CoV-2 region binding domain (RBD) of the Spike protein were computed. The analysis included predictions of biological properties of the peptides, such as antibacterial, antifungal, antiviral, and hemolytic activities.
Figure 6Bioinformatic analysis of human cathelicidin peptide LL-37. Net charge, secondary structure, hydrophobicity of helixes, interaction with membranes and with the SARS-CoV-2 region binding domain (RBD) of the Spike protein were computed. The analysis included predictions of biological properties of the peptides; such as antibacterial, antifungal, antiviral and hemolytic activities.